Organization (Hospital)
Carmel Medical Center
ClinicalTrials.gov lists Carmel Medical Center as lead sponsor of 119 trials. It has 2 active development programs and 14 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 2.0 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Carmel Medical Center: 119 lead-sponsored trials and 1 legal-entity registration.
Disease areas (115)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Multiple Sclerosis | 7 |
| Pain | 7 |
| Asthma | 5 |
| Disease | 4 |
| Premature Birth | 4 |
Showing 5 of 115 disease areas.
Trials by start year as sponsor or collaborator (21)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2024 | 2 |
| 2023 | 6 |
| 2021 | 6 |
| 2020 | 6 |
| 2019 | 10 |
| 2018 | 9 |
| 2017 | 8 |
| 2016 | 5 |
| 2015 | 9 |
Showing 10 of 21 years.
Prediction, not a registry value: median of 34 months from start to primary completion across 6 trials still running at the 2026-10-09 snapshot; 3 of 6 predicted trials reach the 36-month horizon; registered median of 24 months across 53 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (2)
Shown in this order: max phase, then active trials.
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| Chinese herbal formula | Endometriosis | Phase 2 | 1 |
| Caffeine | Fatigue | Not reported | 1 |
Approved assets (14)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| Calcium-vitamin D3 | 1 |
| Inhaled ILOPROST | 1 |
| Intracystic injection of OK432 under US guiding | 1 |
| Prednisone tablet | 1 |
| MIDAZOLAM | 1 |
Showing 5 of 14 approved assets.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 38% hit target (n=13) | 20% on time (n=10) |
Journals published in (101)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 5 |
| BMJ supportive & palliative care | 4 |
| Critical care (London, England) | 4 |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 4 |
| The New England journal of medicine | 4 |
Showing 5 of 101 journals.
Organization relationships (5)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Technion – Israel Institute of Technology | Co sponsors trial with | 4 |
| Poriya Medical Center | Co sponsors trial with | 1 |
| Herb Spirit | Co sponsors trial with | 1 |
| HaEmek Medical Center, Israel | Co sponsors trial with | 1 |
| Pneumedicare Ltd. | Co sponsors trial with | 1 |
Latest dated events (139)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2025-03-16 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-09-04 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-08-28 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2023-11-15 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2023-10-23 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 139 events.
Biomarker capability evidence (26)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| ADM2 | Trial sponsor | Named in trial inclusion criteria |
| CFTR | Trial sponsor | Named in trial inclusion criteria |
| CLNK | Trial sponsor | Named in trial inclusion criteria |
| IFNB1 | Trial sponsor | Named in trial inclusion criteria |
| PAPOLA | Trial sponsor | Named in trial inclusion criteria |
Showing 5 of 26 evidence rows.
Biomarkers this organization publishes on (221)
Shown in this order: most publications first.
Showing 5 of 221 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.